AbbVie· @abbvie · X·· 6 小时前AI 评分42
AI 导读
今日，我们宣布了我们在成人中开展的长效胰淀素类似物I期多次递增剂量研究的详细结果，该结果正在@EASDnews 2026年年会上展示。 了解更多：https://abbv.ie/6e7894 #EASD2026
正文
Today we announced detailed results from our Phase 1 multiple ascending dose study of a long-acting amylin analog in adults being presented at the @EASDnews Annual Meeting 2026.
Learn more: https://abbv.ie/6e7894 #EASD2026
来源：AbbVie · x.com